Upadacitinib trials for Ulcerative colitis

All Upadacitinib trials · All Ulcerative colitis trials

Phase breakdown

Recruiting trials studying Upadacitinib for Ulcerative colitis

• Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）
  NCT07546097 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 4 locations
• Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
  NCT06780683 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 12 locations
• Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
  NCT06095596 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
  NCT07442045 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
  NCT07550673 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 4 locations

Common questions

How many trials study Upadacitinib for Ulcerative colitis?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.